Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010012/S601

ACUITY X4 LV leads

Boston Scientific Corp · Decision date Feb 20, 2026

FDA DECISIONP010012/S601

What did the FDA approve?

FDA records P010012/S601 as a supplement to PMA P010012, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Feb 20, 2026.

FDA approval order statement

to transfer the 100% ethylene oxide (EO) gas sterilization process for the CRM leads from BSC's Dorado, Puerto Rico site to BSC's Coventry, Rhode Island site
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Feb 20, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P010012/S601
Regulatory pathway
PMA supplement
Product code
NIK
Decision code
APPR
Decision date
Feb 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D).

Product code
NIK
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P010012/S591 · Related supplement

    ACUITY X4 Straight, Models 4671 and 4672; ACUITY X4 Spiral S, Models 4674 and 4675; ACUITY X4 Spiral L, Models 4677 and

  2. P010012/S596 · Related supplement

    CONTAK CD,EASYTRAK, LIVIAN, COGNIS AND ACUITY SPIRIAL AUTOMATIC IMPLANTABLE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLL

  3. P010012/S597 · Related supplement

    ACC SUP SUTURE SLEEVE; ACC SUP FLUSHING TOOL; ACC WRENCH TORQUE-BI; ACC SUP LD CAP LV1

  4. P010012/S595 · Related supplement

    Cardiac Resynchronization Therapy Defibrillators INOGEN (Models G140, G141, G146, G148); DYNAGEN (Models G150, G151, G15

  5. P010012/S598 · Related supplement

    G124 MOMENTUM CRT-D, G125 MOMENTUM CRT-D, G126 MOMENTUM CRT-D, G128 MOMENTUM, G138 MOMENTUM X4 CRT-D, G140 INOGEN C

  6. P010012/S599 · Related supplement

    G124 MOMENTUM CRT-D,G125 MOMENTUM CRT-D,G126 MOMENTUM CRT-D,G128 MOMENTUM,G138 MOMENTUM X4 CRT-D,G140 INOGEN CRT-D,

  7. P010012/S601 received

    Application receipt date recorded by FDA.

  8. P010012/S592 · Related supplement

    NG3 Cardiac Resynchronization Therapy Defibrillators (CRT-Ds): DYNAGEN Models: G150, G151, G154, G156, G158; INOGEN Mode

  9. P010012/S602 · Related supplement

    ACUITY X4 Straight/ model 4671; ACUITY X4 Straight/ model 4672; ACUITY X4 Spiral S/ model 4674; ACUITY X4 Spiral S/ mod

  10. P010012/S601 · FDA decision

    Normal 180 Day Track No User Fee

  11. P010012/S603 · Related supplement

    CONTAK CD,EASYTRAK, LIVIAN, COGNIS AND ACUITY SPIRIAL AUTOMATIC IMPLANTABLE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLL

  12. P010012/S605 · Related supplement

    CONTAK CD, EASYTRAK, LIVIAN, COGNIS AND ACUITY SPIRIAL AUTOMATIC IMPLANTABLE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILL

  13. P010012/S604 · Related supplement

    Suture Sleeve Model 4603, 6402 , ACUITY X4 Flushing tool/Wire guide Model 4604, Lead Cap Model 6742, Torque Wrench, Mode

  14. P010012/S594 · Related supplement

    Cardiac Resynchronization Therapy Defibrillators (CRT-D) RESONATE: G524, G525, G526, G528, G537, G547, G548, G424, G425,

  15. P010012/S606 · Related supplement

    ACUITY Spiral (Model 4592); ACUITY X4 Straight (Model 4593); ACUITY X4 Straight (Model 4672); ACUITY X4 Spiral S (Model

  16. P010012/S608 · Related supplement

    ACUITY X4 Suture Sleeve (aka Lead Stabilizer) (Model 4603); ACUITY X4 Flushing Tool/Wire Guide (Model 4604)

  17. P010012/S609 · Related supplement

    MOMENTUM, MOMENTUM X4, INOGEN, DYNAGEN, VIGILANT, VIGILANT X4, RESONATE, RESONATE X4, RESONATE HF

  18. P010012/S610 · Related supplement

    EasyTrak, Acuity Spiral and Acuity x4 Leads: ACuity Spiral Lead Model: 4592 Acuity x4 Lead Models: 4671, 4672, 4674, 467

  19. P010012/S611 · Related supplement

    ACUITY SPIRAL, ACUITY X4 Straight, ACUITY X4 Spiral S, ACUITY X4 Spiral L

  20. P010012/S607 · Related supplement

    COGNIS, ENERGEN, PUNCTUA, INCEPTA, ORIGEN, INOGEN, DYNAGEN, AUTOGEN, RESONATE, MOMENTUM, VIGILIANT

  21. P010012/S613 · Related supplement

    MOMENTUM CRT-D IS1 DF4 IS1 (G124, G125); MOMENTUM CRT-D IS1 DF1 LV1 (G126); MOMENTUM X4 CRT-D IS1 DF1 IS4 (G128, G138

Timeline entries are records held by MedtechLedger for P010012. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010012

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA supplementSep 3, 2025FDA
Boston Scientific CorpPMA supplementSep 16, 2025FDA
Boston Scientific CorpPMA supplementSep 16, 2025FDA
Boston Scientific CorpPMA supplementSep 22, 2025FDA
Boston Scientific CorpPMA supplementOct 22, 2025FDA
Boston Scientific CorpPMA supplementOct 22, 2025FDA
ACUITY X4 LeadsP010012/S593
Boston Scientific CorpPMA supplementOct 24, 2025FDA
Boston Scientific CorpPMA supplementJan 8, 2026FDA
Boston Scientific CorpPMA supplementFeb 13, 2026FDA
Boston Scientific CorpPMA supplementMar 6, 2026FDA
Boston Scientific CorpPMA supplementApr 1, 2026FDA
Boston Scientific CorpPMA supplementApr 10, 2026FDA
Boston Scientific CorpPMA supplementApr 21, 2026FDA
Boston Scientific CorpPMA supplementApr 22, 2026FDA
Boston Scientific CorpPMA supplementMay 15, 2026FDA
Boston Scientific CorpPMA supplementJun 3, 2026FDA
Boston Scientific CorpPMA supplementJun 3, 2026FDA
Boston Scientific CorpPMA supplementJun 9, 2026FDA
Boston Scientific CorpPMA supplementJul 1, 2026FDA
Boston Scientific CorpPMA supplementJul 23, 2026FDA
Boston Scientific CorpPMA supplementAug 25, 2026FDA

Explore the linked device profile

Other records with product code NIK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
4100 Hamline Ave. N, St Paul, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records